-
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma Cancer Sci. (IF 5.7) Pub Date : 2024-03-18 Yasuo Mori, Jun Takizawa, Yuna Katsuoka, Naoki Takezako, Koji Nagafuji, Hiroshi Handa, Junya Kuroda, Kazutaka Sunami, Tomohiko Kamimura, Ryosuke Ogawa, Yoshikane Kikushige, Mine Harada, Koichi Akashi, Toshihiro Miyamoto
-
Correction to “Role of tumor necrosis factor-α and its receptors in human benign breast lesions and tumors (in situ and infiltrative)” Cancer Sci. (IF 5.7) Pub Date : 2024-03-18
García-Tuñón, I., Ricote, M., Ruiz, A., Fraile, B., Paniagua, R. and Royuela, M. (2006), Role of tumor necrosis factor-α and its receptors in human benign breast lesions and tumors (in situ and infiltrative). Cancer Science, 97: 1044–1049. https://doi.org/10.1111/j.1349-7006.2006.00277.x The Western blot bands in Figure 1 were cropped and pasted into a standard background. This type of image processing
-
Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-17 Masahiro Hashimoto, Takaaki Masuda, Yusuke Nakano, Taro Tobo, Hideyuki Saito, Kensuke Koike, Junichi Takahashi, Tadashi Abe, Yuki Ando, Yuki Ozato, Kiyotaka Hosoda, Satoshi Higuchi, Yuichi Hisamatsu, Takeo Toshima, Yusuke Yonemura, Tsuyoshi Hata, Mamoru Uemura, Hidetoshi Eguchi, Yuichiro Doki, Masaki Mori, Koshi Mimori
-
Enhanced lipid biosynthesis in oral squamous cell carcinoma cancer-associated fibroblasts contributes to tumor progression: Role of IL8/AKT/p-ACLY axis Cancer Sci. (IF 5.7) Pub Date : 2024-03-17 Pan Liu, Yue Wang, Xiang Li, Zhenan Liu, Yunqing Sun, Hanzhe Liu, Zhe Shao, Erhui Jiang, Xiaocheng Zhou, Zhengjun Shang
-
Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-15 Zhuo Cheng, Cheng Yang, Qian Zhao, Jingjiao Zhong, Jin Zhang, Riming Jin, Yao Li, Na Ta, Dong Wu, Zhengang Yuan, Wen Sun, Ruoyu Wang
-
Upregulation of HLA‐II related to LAG‐3+CD4+ T cell infiltration is associated with patient outcome in human glioblastoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Wenli Guo, Daijun Peng, Yuee Liao, Lei Lou, Moran Guo, Chen Li, Wangyang Yu, Xiaoxi Tian, Guohui Wang, Ping Lv, Jing Zuo, Haitao Shen, Yuehong Li
-
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Zhiduan Cai, Wenjun Luo, Haoran Wang, Rui Zhu, Yaoji Yuan, Xiangyu Zhan, Mengyuan Xie, Haoquan Zhuang, Haoyu Chen, Yuyu Xu, Xiezhao Li, Leyuan Liu, Guibin Xu
-
Alix‐normalized exosomal programmed death‐ligand 1 analysis in urine enables precision monitoring of urothelial cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Hyun‐Kyung Woo, Juhee Park, Kyung Hwan Kim, Ja Yoon Ku, Hong Koo Ha, Yoon‐Kyoung Cho
-
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-14 Haruna Fujimori, Mao Shima‐Nakamura, Shin‐Ichiro Kanno, Rie Shibuya‐Takahashi, Mai Mochizuki, Masamichi Mizuma, Michiaki Unno, Yuta Wakui, Makoto Abue, Wataru Iwai, Daisuke Fukushi, Kennich Satoh, Kazunori Yamaguchi, Norihisa Shindo, Jun Yasuda, Keiichi Tamai
-
Orosomucoid 2 upregulation mediates liver injury‐induced colorectal cancer liver metastasis by promoting EMT and cell migration Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Xundong Wei, Lei Wang, Bing Yang, Yuanyuan Ma, Wei Yuan, Jie Ma
-
Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Paula Duch, Natalia Díaz‐Valdivia, Marta Gabasa, Rafael Ikemori, Marselina Arshakyan, Patricia Fernández‐Nogueira, Alejandro Llorente, Cristina Teixido, Josep Ramírez, Javier Pereda, Lourdes Chuliá‐Peris, José Marcelo Galbis, Frank Hilberg, Noemí Reguart, Derek C. Radisky, Jordi Alcaraz
-
Serum ITIH5 as a novel diagnostic biomarker in cholangiocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Meiru Chen, Jinghan Ma, Xiaoli Xie, Miao Su, Dongqiang Zhao
-
KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Kazuya Kato, Takehiro Noda, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hidenori Takahashi, Mamoru Uemura, Tadafumi Asaoka, Junzo Shimizu, Yuichiro Doki, Hidetoshi Eguchi
-
LncRNA CTBP1‐AS inhibits TP63‐mediated activation of S100A14 during prostate cancer progression Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Guangzheng Wu, Zhenkun Dong, Yuhang Dong, Yinmei Chen, Huan Zhu, Dexin Ding, Yan Cui, Yiwen Wang, Yangyang Xu, Hui Chen
-
ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Jee Soo Park, Hongkyung Kim, Won Sik Jang, Jongchan Kim, Won Sik Ham, Seung‐Tae Lee
-
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway Cancer Sci. (IF 5.7) Pub Date : 2024-03-13 Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
-
RB1 loss induces quiescent state through downregulation of RAS signaling in mammary epithelial cells Cancer Sci. (IF 5.7) Pub Date : 2024-03-12 Linxiang Gong, Dominic Chih‐Cheng Voon, Joji Nakayama, Chiaki Takahashi, Susumu Kohno
-
-
In this issue Cancer Sci. (IF 5.7) Pub Date : 2024-03-08
Anti-angiogenesis in colorectal cancer therapy Colorectal cancer (CRC) is the third most common type of cancer worldwide, making it a significant health concern. This type of cancer generally begins with the abnormal growth of cells in the colon or rectum and may eventually transform to a malignant cancer that spreads to other organs. The key to the progression of CRC lies in a process called angiogenesis
-
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non‐small cell lung cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-07 Masaki Ishida, Masahiro Iwasaku, Toshifumi Doi, Takeshi Ishikawa, Yusuke Tachibana, Ryo Sawada, Yuri Ogura, Hayato Kawachi, Yuki Katayama, Naoya Nishioka, Kenji Morimoto, Shinsaku Tokuda, Tadaaki Yamada, Koichi Takayama
-
Serum and tissue metallome of pancreatic ductal adenocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Sooin Byeon, Taymin du Toit-Thompson, Luke Hipperson, Sarah Maloney, Ross Wenzel, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni
-
SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression Cancer Sci. (IF 5.7) Pub Date : 2024-03-05 Zhenyu Zhou, Zheng Chen, Qianlei Zhou, Shiyu Meng, Juanyi Shi, Sintim Mui, Hai Jiang, Jianhong Lin, Gui He, Wenbin Li, Jianlong Zhang, Jie Wang, Chuanchao He, Yongcong Yan, Zhiyu Xiao
-
Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Mayumi Kobayashi Kato, Erisa Fujii, Yuka Asami, Yukihide Momozawa, Kengo Hiranuma, Masaaki Komatsu, Ryuji Hamamoto, Takahiro Ebata, Koji Matsumoto, Mitsuya Ishikawa, Takashi Kohno, Tomoyasu Kato, Hiroshi Yoshida, Kouya Shiraishi
-
ILT4 facilitates angiogenesis in non‐small cell lung cancer Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Shuyun Wang, Jing Wang, Wenjing Gong, Fang Zhang, Xiaozheng Chen, Huijun Xu, Yali Han, Xuebing Fu, Leirong Wang, Juan Li, Aiqin Gao, Yuping Sun
-
Region‐specific DNA hydroxymethylation along the malignant progression of IDH‐mutant gliomas Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Taijun Hana, Akitake Mukasa, Masashi Nomura, Genta Nagae, Shogo Yamamoto, Kenji Tatsuno, Hiroki Ueda, Shiro Fukuda, Takayoshi Umeda, Shota Tanaka, Takahide Nejo, Yosuke Kitagawa, Erika Yamazawa, Satoshi Takahashi, Tsukasa Koike, Yoshihiro Kushihara, Hirokazu Takami, Shunsaku Takayanagi, Hiroyuki Aburatani, Nobuhito Saito
-
Mitochondrial fission enhances IL‐6‐induced metastatic potential in ovarian cancer via ERK1/2 activation Cancer Sci. (IF 5.7) Pub Date : 2024-03-04 Juwon Lee, Youngjin Han, Soochi Kim, HyunA Jo, Wenyu Wang, Untack Cho, Se Ik Kim, Boyun Kim, Yong Sang Song
-
Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential Cancer Sci. (IF 5.7) Pub Date : 2024-03-02 Tadayoshi Hashimoto, Yoshiaki Nakamura, Saori Mishima, Izuma Nakayama, Daisuke Kotani, Akihito Kawazoe, Yasutoshi Kuboki, Hideaki Bando, Takashi Kojima, Naoko Iida, Taro Shibuki, Mitsuho Imai, Takao Fujisawa, Michiko Nagamine, Naoya Sakamoto, Takeshi Kuwata, Takayuki Yoshino, Kohei Shitara
-
-
Development and experimental validation of an M2 macrophage and platelet‐associated gene signature to predict prognosis and immunotherapy sensitivity in bladder cancer Cancer Sci. (IF 5.7) Pub Date : 2024-02-29 Bahaerguli Muhuitijiang, Jiawei Zhou, Ranran Zhou, Zhiyong Zhang, Guang Yan, Zaosong Zheng, Xiangbo Zeng, Yuanchao Zhu, Haowei Wu, Ruxi Gao, Tianhang Zhu, Xiaojun Shi, Wanlong Tan
-
Salivary metabolomic biomarkers for non‐invasive lung cancer detection Cancer Sci. (IF 5.7) Pub Date : 2024-02-28 Naohiro Kajiwara, Masatoshi Kakihana, Junichi Maeda, Miku Kaneko, Sana Ota, Ayame Enomoto, Norihiko Ikeda, Masahiro Sugimoto
-
Cell cycle heterogeneity and plasticity of colorectal cancer stem cells Cancer Sci. (IF 5.7) Pub Date : 2024-02-28 Tsunaki Higa, Keiichi I. Nakayama
-
Hypoxia‐related carbonic anhydrase 9 induces serpinB9 expression in cancer cells and apoptosis in T cells via acidosis Cancer Sci. (IF 5.7) Pub Date : 2024-02-28 Mamoru Harada, Hitoshi Kotani, Yuichi Iida, Ryosuke Tanino, Takafumi Minami, Yoshihiro Komohara, Kazuhiro Yoshikawa, Hirotsugu Uemura
-
Correction to: HDAC5, Negatively regulated by miR‐ 148a‐ 3p, promotes colon cancer cell migration Cancer Sci. (IF 5.7) Pub Date : 2024-02-27
[OuYang C, Shu G, Liu J, et al. HDAC5, negatively regulated by miR-148a-3p, promotes colon cancer cell migration. Cancer Sci. 2022;113:2560–2574. https://doi.org/10.1111/cas.15399.] In the initially published version of this article, there were issues with the images of si-DAC5/invasion in Figure 2D and HDAC5/migration in Figure 2G. The corrected Figure 2 is shown below. These corrections will not
-
Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations Cancer Sci. (IF 5.7) Pub Date : 2024-02-27 Hizuru Amano, Hiroo Uchida, Kazuharu Harada, Atsushi Narita, Shigehisa Fumino, Yuji Yamada, Shun Kumano, Mayumi Abe, Takashi Ishigaki, Minoru Sakairi, Chiyoe Shirota, Takahisa Tainaka, Wataru Sumida, Kazuki Yokota, Satoshi Makita, Shuhei Karakawa, Yuichi Mitani, Shojiro Matsumoto, Yutaka Tomioka, Hideki Muramatsu, Nobuhiro Nishio, Tsuyoshi Osawa, Masataka Taguri, Katsuyoshi Koh, Tatsuro Tajiri, Motohiro
-
Acid‐sensing receptor GPR4 plays a crucial role in lymphatic cancer metastasis Cancer Sci. (IF 5.7) Pub Date : 2024-02-27 Masako Nakanishi, Akiya Ibe, Kiyoto Morishita, Kazutaka Shinagawa, Yushi Yamamoto, Hibiki Takahashi, Kyoka Ikemori, Yasuteru Muragaki, Shogo Ehata
-
Harnessing the potential of reverse‐phase protein array technology: Advancing precision oncology strategies Cancer Sci. (IF 5.7) Pub Date : 2024-02-27 Mari Masuda, Riko Nakagawa, Tadashi Kondo
-
FoxO1 promotes ovarian cancer by increasing transcription and METTL14‐mediated m6A modification of SMC4 Cancer Sci. (IF 5.7) Pub Date : 2024-02-26 Liping Tan, Shuangan Wang, Shijia Huang, Yujuan Tie, Na Sai, Yichen Mao, Shuli Zhao, Yayi Hou, Huan Dou
-
Integration of CD4+ T cells and molecular subtype predicts benefit from PD‐L1 blockade in muscle‐invasive bladder cancer Cancer Sci. (IF 5.7) Pub Date : 2024-02-25 Ge Liu, Kaifeng Jin, Zhaopei Liu, Xiaohe Su, Ziyue Xu, Bingyu Li, Jingtong Xu, Hailong Liu, Yuan Chang, Yu Zhu, Le Xu, Zewei Wang, Yiwei Wang, Weijuan Zhang
-
Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study Cancer Sci. (IF 5.7) Pub Date : 2024-02-25 Masahiro Morise, Terufumi Kato, Shingo Matsumoto, Takako Inoue, Tomohiro Sakamoto, Takaaki Tokito, Shinji Atagi, Toshiyuki Kozuki, Hiroaki Takeoka, Kenichi Chikamori, Naofumi Shinagawa, Hiroshi Tanaka, Eisuke Horii, Svenja Adrian, Rolf Bruns, Andreas Johne, Paul K. Paik, Hiroshi Sakai
-
Emerging potential of immunopeptidomics by mass spectrometry in cancer immunotherapy Cancer Sci. (IF 5.7) Pub Date : 2024-02-21 Yuriko Minegishi, Yoshimi Haga, Koji Ueda
-
Cross‐individual cancer transmission to children during the gestational and perinatal periods Cancer Sci. (IF 5.7) Pub Date : 2024-02-19 Ayumu Arakawa, Kayoko Tao, Takashi Kohno, Chitose Ogawa
-
Dietary melatonin and liver cancer incidence in Japan: From the Takayama study Cancer Sci. (IF 5.7) Pub Date : 2024-02-14 Keiko Wada, Atsuhiko Hattori, Yusuke Maruyama, Tomoka Mori, Masaaki Sugino, Yuma Nakashima, Michiyo Yamakawa, Masayuki Yamamoto, Akihiro Hori, Mitsuru Seishima, Shinobu Tanabashi, Shogen Matsushita, Chisato Nagata
-
Phase I trial of apatinib and paclitaxel+oxaliplatin+5-FU/levoleucovorin for treatment-naïve advanced gastric cancer Cancer Sci. (IF 5.7) Pub Date : 2024-02-14 Shen Zhao, LiYu Su, Feng Huang, Changhua Zhuo, Zaisheng Ye, Hui Li, Yi Yin, Pengqiang Gao, Yong Zhu, Rongbo Lin
-
Transient inhibition of neutrophil functions enhances the antitumor effect of intravenously delivered oncolytic vaccinia virus Cancer Sci. (IF 5.7) Pub Date : 2024-02-13 Danya Zhou, Wei Xu, Xuping Ding, Haoran Guo, Jianyao Wang, Guanghao Zhao, Chenglin Zhang, Zhongxian Zhang, Zhimin Wang, Pengju Wang, Liming Lu, Ming Yuan
-
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer Cancer Sci. (IF 5.7) Pub Date : 2024-02-13 Mi Rim Lee, Sang Myung Woo, Min Kyeong Kim, Sung-Sik Han, Sang-Jae Park, Woo Jin Lee, Dong-eun Lee, Sun Il Choi, Wonyoung Choi, Kyong-Ah Yoon, Jung Won Chun, Yun-Hee Kim, Sun-Young Kong
-
Retraction Cancer Sci. (IF 5.7) Pub Date : 2024-02-11
Retraction: Tongyi Lu, Binhua Wu, Yunfei Yu, Wenhui Zhu, Simin Zhang, Yinmei Zhang, Jiaying Guo, Ning Deng. Blockade of ONECUT2 expression in ovarian cancer inhibited tumor cell proliferation, migration, invasion and angiogenesis. Cancer Sci. 2018; 109: 2221–2234. https://doi.org/10.1111/cas.13633
-
Gap junction beta-4 accelerates cell cycle progression and metastasis through MET–AKT activation in pancreatic cancer Cancer Sci. (IF 5.7) Pub Date : 2024-02-11 Joji Muramatsu, Yohei Arihara, Makoto Yoshida, Tomohiro Kubo, Hajime Nakamura, Kazuma Ishikawa, Hiromi Fujita, Shintaro Sugita, Takumi Konno, Takashi Kojima, Yutaka Kawano, Masayoshi Kobune, Kohichi Takada
-
In this issue Cancer Sci. (IF 5.7) Pub Date : 2024-02-11
Oral bacterium Streptococcus mutans promotes tumor metastasis through thrombosis formation Bacteria that colonize the human mouth are known to enter the bloodstream due to oral diseases, such as periodontitis. Clinical evidence suggests that oral bacteria in the blood increase the incidence of cardiovascular complications and promote the migration or ‘metastasis’ of cancer cells. The oral bacterium
-
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8 Cancer Sci. (IF 5.7) Pub Date : 2024-02-08 Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
-
Glasdegib with intensive/nonintensive chemotherapy in Japanese patients with untreated acute myeloid leukemia or high-risk myelodysplastic syndromes Cancer Sci. (IF 5.7) Pub Date : 2024-02-07 Koji Izutsu, Kumi Ubukawa, Takanobu Morishita, Yasushi Onishi, Kenichi Ishizawa, Yosuke Fujii, Nobuyuki Kimura, Miyuu Yokochi, Tomoki Naoe
-
Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer Cancer Sci. (IF 5.7) Pub Date : 2024-02-06 Takahiro Yamanaka, Kenichiro Araki, Takehiko Yokobori, Ryo Muranushi, Kouki Hoshino, Kei Hagiwara, Dolgormaa Gantumur, Norihiro Ishii, Mariko Tsukagoshi, Akira Watanabe, Norifumi Harimoto, Atsushi Masamune, Haruki Uojima, Masashi Mizokami, Kiyoaki Ito, Ken Shirabe
-
Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma Cancer Sci. (IF 5.7) Pub Date : 2024-02-06 Junki Fukuda, Shinya Kosuge, Yusuke Satoh, Sho Sekiya, Ryodai Yamamura, Takako Ooshio, Taiga Hirata, Reo Sato, Kanako C. Hatanaka, Tomoko Mitsuhashi, Toru Nakamura, Yoshihiro Matsuno, Yutaka Hatanaka, Satoshi Hirano, Masahiro Sonoshita
-
Blueprints from plane to space: outlook of next-generation three-dimensional histopathology Cancer Sci. (IF 5.7) Pub Date : 2024-02-05 Akira Leon Yoshikawa, Takaki Omura, Atsushi Takahashi-Kanemitsu, Etsuo A. Susaki
-
Body mass index and lung cancer risk: Pooled analysis of 10 prospective cohort studies in Japan Cancer Sci. (IF 5.7) Pub Date : 2024-02-04 Sayo Kawai, Yingsong Lin, Hiroshi Tsuge, Hidemi Ito, Keitaro Matsuo, Keiko Wada, Chisato Nagata, Nobuhiro Narii, Tetsuhisa Kitamura, Mai Utada, Ritsu Sakata, Takashi Kimura, Akiko Tamakoshi, Yumi Sugawara, Ichiro Tsuji, Seitaro Suzuki, Norie Sawada, Shoichiro Tsugane, Tetsuya Mizoue, Isao Oze, Sarah Krull Abe, Manami Inoue
Mounting evidence suggests that body mass index (BMI) is inversely associated with the risk of lung cancer. However, relatively few studies have explored this association in Asian people, who have a much lower prevalence of obesity than Caucasians. We pooled data from 10 prospective cohort studies involving 444,143 Japanese men and women to address the association between BMI and the risk of lung cancer
-
Pks-positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients Cancer Sci. (IF 5.7) Pub Date : 2024-01-31 Toshimitsu Miyasaka, Takeshi Yamada, Kay Uehara, Hiromichi Sonoda, Akihisa Matsuda, Seiichi Shinji, Ryo Ohta, Sho Kuriyama, Yasuyuki Yokoyama, Goro Takahashi, Takuma Iwai, Kohki Takeda, Koji Ueda, Shintaro Kanaka, Ryuji Ohashi, Hiroshi Yoshida
-
Regulator of G protein signaling 1 is a potential target in gastric cancer and impacts tumor-associated macrophages Cancer Sci. (IF 5.7) Pub Date : 2024-01-30 Mengting Wu, Xuefei Xu, Chuqi Yang, Qingwen An, Jingcheng Zhang, Zhengqi Zhao, Yewen Feng, Weiyu Liang, Yufei Fu, Guangji Zhang, Tao Jiang
-
SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1 Cancer Sci. (IF 5.7) Pub Date : 2024-01-30 Yiying Gu, Cong Ding, Tingzi Yu, Bohao Liu, Wenbin Tang, Zhiqiang Wang, Xiaohui Tang, Gaoshuang Liang, Jinying Peng, Xiangwen Zhang, Zhuan Li
-
BRCC36 associates with FLT3-ITD to regulate its protein stability and intracellular signaling in acute myeloid leukemia Cancer Sci. (IF 5.7) Pub Date : 2024-01-30 Jianwei Liu, Tomoya Isaji, Sachiko Komatsu, Yuhan Sun, Xing Xu, Tomohiko Fukuda, Tsutomu Fujimura, Shinichiro Takahashi, Jianguo Gu
-
An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity Cancer Sci. (IF 5.7) Pub Date : 2024-01-29 Jean-Pierre Bikorimana, Jamilah Abusarah, Marina Gonçalves, Roudy Farah, Wael Saad, Sebastien Talbot, Daniela Stanga, Simon Beaudoin, Sebastien Plouffe, Moutih Rafei
-
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101) Cancer Sci. (IF 5.7) Pub Date : 2024-01-29 Kosuke Tsuji, Hidenori Mizugaki, Keiki Yokoo, Maki Kobayashi, Yosuke Kawashima, Nozomu Kimura, Hiroshi Yokouchi, Hajime Kikuchi, Toshiyuki Sumi, Yasutaka Kawai, Kenta Kobashi, Ryo Morita, Kenichiro Ito, Yasuo Kitamura, Hiroyuki Minemura, Keiichi Nakamura, Mari Aso, Osamu Honjo, Hisashi Tanaka, Taichi Takashina, Kyoji Tsurumi, Jun Sugisaka, Yoko Tsukita, Satoshi Konno, Satoshi Oizumi